After Decades, A Gene Therapy Is Approved. Next: The Debate On Price – Forbes
Forbes |
After Decades, A Gene Therapy Is Approved. Next: The Debate On Price
Forbes This morning the Food and Drug Administration approved Luxturna, a gene therapy to treat a rare form of blindness in kids and adults that will be sold by Philadelphia-based Spark Therapeutics. "The culmination of decades of research has resulted in … FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss First Gene Therapy For Inherited Disease Gets FDA Approval FDA Approves First Gene Therapy Targeting Rare Form of Inherited Blindness |
